Effects of NS-398 on NF-κB in Colorectal Cancer Cells
Author Information
Author(s): Smartt H J M, Elder D J E, Hicks D J, Williams N A, Paraskeva C
Primary Institution: University of Bristol
Hypothesis
Does the COX-2-selective inhibitor NS-398 affect NF-κB activity during apoptosis in colorectal carcinoma cells?
Conclusion
NS-398 increases NF-κB DNA-binding activity at later time points but does not enhance transcriptional activity or apoptosis in colorectal cancer cells.
Supporting Evidence
- NS-398 treatment increased the proportion of floating cells, indicating apoptosis.
- NF-κB DNA-binding activity was significantly increased at 72 and 96 hours post-treatment.
- Blocking NF-κB activation did not enhance apoptosis induced by NS-398.
Takeaway
This study looks at how a drug called NS-398 affects a protein called NF-κB in cancer cells. It found that while the drug can change NF-κB's activity, it doesn't help the cancer cells die.
Methodology
HT-29 colon carcinoma cells were treated with NS-398, and NF-κB DNA-binding activity was measured at various time points using EMSA.
Limitations
The study primarily focuses on one cell line and may not generalize to all colorectal cancer types.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website